Innovative Cellular Therapeutics Holdings reports Lyell Immunopharma share sale worth $137

Reuters2026/07/20 18:56

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Innovative Cellular Therapeutics Holdings Ltd disclosed a sale of 10 Lyell Immunopharma common shares on July 17, 2026.
Shares were sold at USD 13.7, leaving the holder with 2,857,480 shares.
The filing lists the seller as a 10% owner.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-028955), on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Innovative Cellular Therapeutics Holdings reports Lyell Immunopharma share sale worth $137

You may also like

Crypto prices